NAPROXEN
- Product NDC
- 60760-561
- Requested package NDC
- 60760-561-15
- 11-digit product format
- 607600561
- Labeler code
- 60760
- Product ID
- 60760-561_b2d3ba5f-f3ff-3a79-e053-2995a90a50fe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2020-10-17
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 60760-561 | 60760-561-15 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091416-001 | NAPROXEN | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | |
| A091416-002 | NAPROXEN | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | |
| A091416-003 | NAPROXEN | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091416-001 | AB |
| A091416-002 | AB |
| A091416-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091416-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091416-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091416-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091416-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091416-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091416-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A091416-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091416-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091416-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091416-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091416-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091416-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091416-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091416-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091416-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091416-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091416-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091416-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091416-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091416-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091416-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091416-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091416-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091416-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091416-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091416-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091416-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A091416-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091416-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091416-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091416-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091416-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091416-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091416-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091416-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091416-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091416-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091416-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091416-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A091416-001 | AB | 1 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NAPROXEN | NAPROXEN | Northwind Health Company, LLC | f32d755e-4984-ee40-e053-2995a90a4ebe | 2026-01-01 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | QPharma Inc | c0a4839b-7154-c82c-e053-2a95a90a7e6d | 2025-12-03 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | a9f9ce81-9d51-4167-9581-974866a8fe31 | 2025-10-17 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | DIRECT RX | b1b78c49-82e9-2402-e053-2a95a90ae35f | 2025-01-17 | Warnings | 091416 ANDA091416 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9a96cf-1cda-8ace-e053-2a95a90a18cc | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 091416 ANDA091416 |
| Naproxen | NAPROXEN | MARKSANS PHARMA LIMITED | 1fdb4cbd-e9e8-47bb-b3d8-1f1ec8f411c8 | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 5487dee2-5c37-4348-e054-00144ff8d46c | 2024-07-17 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 71d4a048-ca50-73db-e053-2a95a90ad465 | 2024-06-10 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 69366b55-2687-17a4-e053-2a91aa0a65b3 | 2024-06-07 | 091416 ANDA091416 | |
| NAPROXEN | NAPROXEN | Asclemed USA, Inc. | a4fcb411-c918-459b-adc6-06dfa8ed8a50 | 2022-10-12 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | 32693390-763b-46dd-b821-65a7bf3c6671 | 2021-04-26 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | Bryant Ranch Prepack | 5d399bf3-db49-411a-91b9-b410d702a65a | 2020-12-14 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | TIME CAP LABORATORIES | 4350a2d9-5228-460e-b7b1-27e8fa846787 | 2018-10-09 | Warnings | 091416 ANDA091416 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60760-561-15 | 60760056115 | 15 TABLET in 1 BOTTLE, PLASTIC (60760-561-15) | 15 tablet | 2020-10-17 | 0000-00-00 | No | No | Current |